| Literature DB >> 33531709 |
Houriiyah Tegally1, Eduan Wilkinson1, Richard J Lessells1, Jennifer Giandhari1, Sureshnee Pillay1, Nokukhanya Msomi2, Koleka Mlisana3, Jinal N Bhiman4, Anne von Gottberg4,5, Sibongile Walaza4,6, Vagner Fonseca1, Mushal Allam4, Arshad Ismail4, Allison J Glass5,7, Susan Engelbrecht8, Gert Van Zyl8, Wolfgang Preiser8, Carolyn Williamson9, Francesco Petruccione10,11, Alex Sigal12,13,14, Inbal Gazy1, Diana Hardie9, Nei-Yuan Hsiao9, Darren Martin15, Denis York16, Dominique Goedhals17, Emmanuel James San1, Marta Giovanetti18, José Lourenço19, Luiz Carlos Junior Alcantara18,20, Tulio de Oliveira21,22,23.
Abstract
The first severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in South Africa was identified on 5 March 2020, and by 26 March the country was in full lockdown (Oxford stringency index of 90)1. Despite the early response, by November 2020, over 785,000 people in South Africa were infected, which accounted for approximately 50% of all known African infections2. In this study, we analyzed 1,365 near whole genomes and report the identification of 16 new lineages of SARS-CoV-2 isolated between 6 March and 26 August 2020. Most of these lineages have unique mutations that have not been identified elsewhere. We also show that three lineages (B.1.1.54, B.1.1.56 and C.1) spread widely in South Africa during the first wave, comprising ~42% of all infections in the country at the time. The newly identified C lineage of SARS-CoV-2, C.1, which has 16 nucleotide mutations as compared with the original Wuhan sequence, including one amino acid change on the spike protein, D614G (ref. 3), was the most geographically widespread lineage in South Africa by the end of August 2020. An early South African-specific lineage, B.1.106, which was identified in April 2020 (ref. 4), became extinct after nosocomial outbreaks were controlled in KwaZulu-Natal Province. Our findings show that genomic surveillance can be implemented on a large scale in Africa to identify new lineages and inform measures to control the spread of SARS-CoV-2. Such genomic surveillance presented in this study has been shown to be crucial in the identification of the 501Y.V2 variant in South Africa in December 2020 (ref. 5).Entities:
Mesh:
Year: 2021 PMID: 33531709 DOI: 10.1038/s41591-021-01255-3
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440